3ŒŽ29“ú(ç«)@14:30~16:30@F‰ïê パシフィコ横浜 会è°ã‚»ãƒ³ã‚¿ãƒ¼ã€€3F 311+312 IS02 FIPフォーラム2016:科å¦ã¨å®Ÿå‹™ã®èžåˆã«å‘ã‘ãŸæ—¥æœ¬ã®è–¬å¦ã®åº•åŠ› FIP Forum 2016: Potential of Japanese Pharmacy toward the Integration of Science and Practice オーガナイザー:熊本 å“哉 IS02-1 抗å‡å›ºè–¬ãƒ¯ãƒ«ãƒ•ã‚¡ãƒªãƒ³ã®PK/PDã®äººç¨®å·®ã¨æŠ•ä¸Žã‚¢ãƒ«ã‚´ãƒªã‚ºãƒ ã®è©•ä¾¡ Ethnic differences in PK/PD of warfarin: implications for the dosing algorithms ƒVƒ“ƒ|ƒWƒXƒg F ○高橋 晴美ã€CAVALLARI Larisaã€LEE Michaelã€KIM Richardã€PADRINI Roberto IS02-2 分å標的抗ãŒã‚“剤ã®è¡€ä¸æ¿ƒåº¦æ¸¬å®šæ–¹æ³•ã®é–‹ç™ºã¨è‡¨åºŠå¿œç”¨ Development and application of analytical methods for determination of tyrosine kinase inhibitors in human plasma ƒVƒ“ƒ|ƒWƒXƒg F ○三浦 昌朋 IS02-3 æ¥å‹™ã¨ç ”究ã®èžåˆã®æ–¹å‘性:薬剤師ã®æžœãŸã™å½¹å‰² Toward the Integration of Practice and Science: The Role of Pharmacists ƒVƒ“ƒ|ƒWƒXƒg F ○鈴木 æ´‹å² IS02-4 Pharmaceutical Sciences in the Future: A Global Perspective Pharmaceutical Sciences in the Future: A Global Perspective ƒVƒ“ƒ|ƒWƒXƒg F â—‹PAULETTI Giovanni M. ŒŸõƒy[ƒW‚É–ß‚é